SCHEMBL4838367

SCHEMBL4838367

COc1ccc2c(c1)C(=CC(=O)c1ccc(NC(=O)c3cc(Cl)cc(Cl)c3)cc1)NC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAS1R3 Q7RTX0 1/20 0.41
TAS1R1 Q7RTX1 1/20 0.41
TAS1R2 Q8TE23 1/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
RAB9A P51151 4/20 0.40
NPC1 O15118 4/20 0.40
TP53 P04637 2/20 0.40
GSK3B P49841 1/20 0.40
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAPT P10636 3/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
F10 P00742 2/20 0.39
PLAU P00749 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
LMNA P02545 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838356 1.00 TAS1R3 (0.41) TAS1R3TAS1R1TAS1R2KMT2AMEN1
SCHEMBL4846510 0.94 TP53 (0.44) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4846498 0.94 TP53 (0.44) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4835436 0.92 RAB9A (0.49) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4835417 0.92 RAB9A (0.49) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4834867 0.92 KMT2A (0.43) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4834858 0.92 KMT2A (0.43) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4839109 0.92 RAB9A (0.49) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4839102 0.92 RAB9A (0.49) KMT2AMEN1RAB9ANPC1TP53
SCHEMBL4843729 0.91 RAB9A (0.47) KMT2AMEN1RAB9ANPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 TAS1R3 4367/4885TAS1R1 3883/4885TAS1R2 4551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.